The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Oral Semaglutide for Weight Loss in Non-Diabetics — What UK Adults Need to Know
Oral semaglutide is a prescription weight loss medication available in the UK for adults without diabetes who meet specific eligibility criteria. Unlike insulin injections for diabetes, semaglutide is a GLP-1 receptor agonist that works by regulating appetite and helping you feel fuller for longer. In the UK, most people access semaglutide through either NHS specialist tier 3 weight management services or private online prescribing. This guide explains how it works, who can access it, and what the evidence shows for non-diabetic weight loss.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
NHS Eligibility and How Semaglutide Works for Non-Diabetics
In the UK, semaglutide 2.4mg (brand name Wegovy) is licensed specifically for weight management in adults without type 2 diabetes. Eligibility requires a BMI of 30 kg/m² or higher, or a BMI of 27–29.9 kg/m² with at least one weight-related health condition such as high blood pressure, high cholesterol, or sleep apnoea.
The medication is a GLP-1 receptor agonist — it activates the GLP-1 hormone pathway in your gut and brain to reduce appetite, slow stomach emptying, and support feeling satisfied with smaller meals. Clinical trials (the STEP-1 trial) showed that adults on semaglutide 2.4mg lost an average of approximately 15% of their body weight over 68 weeks, alongside reduced-calorie diet and increased physical activity. Individual results vary significantly.
Access routes in the UK: You can access semaglutide through NHS specialist weight management services (tier 3) following a GP referral, though waiting lists can be lengthy in many areas. Alternatively, private prescribing through UK-licensed online services is available without NHS referral. Our free GLP-1 weight loss calculator can help you estimate potential weight loss projections at different doses.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
NHS vs Private Routes and Important Considerations
NHS access: Requires GP referral to a tier 3 specialist weight management service. NICE has approved semaglutide (Novo Nordisk's Wegovy) for use within NHS services, but availability and waiting times vary significantly by region and integrated care board (ICB). Some areas have extended waiting lists; others have limited access.
Private access: Available through GPhC-registered online pharmacies following a clinical assessment with a UK-licensed prescriber. No NHS referral needed. Costs typically range from £129–£250 per month depending on dose.
Important notes: Semaglutide is prescription-only and requires clinical assessment before prescribing. It is not suitable during pregnancy or breastfeeding. Do not confuse Wegovy (semaglutide 2.4mg for weight management) with Ozempic (semaglutide up to 2mg for type 2 diabetes). Track your progress with our free progress tracker if you start treatment. Always inform your prescriber of all medications.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is semaglutide safe for non-diabetic adults?
Semaglutide is licensed in the UK for weight management in non-diabetic adults and has been used safely in clinical trials. The STEP-1 trial involved non-diabetic participants and showed it was generally well-tolerated. Common side effects include nausea, diarrhoea, and constipation, usually temporary. Serious side effects are rare but can include pancreatitis. Always discuss risks and benefits with your prescriber before starting treatment.
How is oral semaglutide different from the injection?
Wegovy, the UK-licensed semaglutide for weight loss, is a once-weekly injection, not an oral (tablet) form. Currently, semaglutide tablets are only approved for type 2 diabetes in the UK (Rybelsus), not for weight management. Weight loss semaglutide in the UK is administered by weekly self-injection using a pre-filled pen.
What does the NHS STEP trial evidence show about weight loss?
The STEP-1 clinical trial showed that adults on semaglutide 2.4mg lost an average of around 15% of their body weight over 68 weeks, compared to approximately 2.4% with placebo. Results were achieved alongside a reduced-calorie diet and increased physical activity. Individual results vary based on genetics, adherence, diet, and lifestyle. Use our GLP-1 weight loss calculator to see potential projections based on clinical evidence.
Can I access semaglutide through the NHS without a waiting list?
NHS access depends on your region's integrated care board (ICB) and local tier 3 weight management service capacity. Many areas have significant waiting lists, some exceeding 12 months. Check with your GP about local availability and waiting times. If NHS waiting is too long, private prescribing routes are available and faster, though they involve out-of-pocket costs.
What happens when I stop taking semaglutide?
Weight loss achieved with semaglutide is maintained by continued healthy eating and physical activity habits. If you stop taking it without maintaining lifestyle changes, weight regain can occur. It is typically used as part of a comprehensive weight management approach, not as a standalone solution. Discuss long-term plans with your prescriber.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.